dorsaVi Signs First French Distribution Deal

The non-exclusive agreement with LuxingSport is the company's first distributor in France and part of a broader distributor-led expansion plan.

Updated on Nov. 19, 2026 in Corporate Finance

Isometric editorial illustration of a small matte wearable sensor resting on a wooden crate beside stacked shipping crates in muted oxblood, teal, and mustard tones.
dorsaVi Limited signed its first French distribution agreement with LuxingSport, led by Laurent Massias, to bring its wearable movement-monitoring products to professional sports organisations, physiotherapists and research groups. AI Illustration. Upload story photo >

dorsaVi Limited (ASX: DVL) has signed its first French distribution agreement with LuxingSport, a France-based company headed by Laurent Massias. The non-exclusive deal will see LuxingSport introduce dorsaVi products to professional sporting organisations, physiotherapists and research groups.

Why it matters

The agreement shows dorsaVi relying on established distributor networks rather than building large sales teams in each new market. For international readers, it signals how the company intends to scale its wearable movement-monitoring technology across Europe and Asia.

The agreement runs for an initial 12 months and renews automatically each year unless either party gives 90 days' notice, with LuxingSport buying products and subscriptions for resale without minimum purchase quantities. Sales volumes, pricing and expected French revenue have not been disclosed.

The players

dorsaVi Limited (ASX: DVL)

An Australian company that develops wearable technology for monitoring human movement, used in elite sport, clinical treatment and workplace settings.

LuxingSport

A France-based sports distribution company that will sell dorsaVi products and subscriptions to professional sporting organisations, physiotherapists and research groups.

Laurent Massias

The head of LuxingSport, who approached dorsaVi several months before the distribution agreement was signed.

The details

LuxingSport will draw on its existing sales network to reach customers, and dorsaVi will rely on the distributor's relationships and local market knowledge instead of recruiting a separate French salesforce. Massias approached dorsaVi several months before the deal was signed, and the company's technology has previously been used in elite sport, clinical treatment and workplace settings.

Timeline

  1. November 2026: Initial French sales activity is expected to begin.

  2. December 2026: Initial French sales activity is expected to continue.

  3. 2027: The partners plan a broader French market-development campaign.

Market Dynamics

The French deal extends dorsaVi's wearable movement-monitoring platform, which has already been adopted by Boeing, Caterpillar and Medtronic, into European sports and physiotherapy markets. It follows a distributor-led model that avoids building separate sales teams in each new jurisdiction.

For shareholders, the distributor-led model may reduce the fixed cost of entering new markets, though the non-exclusive structure means revenue growth depends on LuxingSport's sales performance. Investors will need to wait for future disclosures to judge how much the French agreement contributes to earnings.

The takeaway

Distributor partnerships can let a growing company enter new markets without the cost of building local sales teams, but the arrangement's success will depend on the partner's execution. Readers tracking dorsaVi should watch for sales updates from late 2026.

What happens next

Initial French sales activity is expected to begin in November 2026, and the broader French market-development campaign is planned for 2027.

Further reading

For more on how companies structure international deals, explore Corporate Finance.

Source note: This article includes information reported by Small Caps.